Open access
Sep 2026
Identification of biomarkers associated with enhanced survival in lung cancer patients undergoing immune checkpoint inhibitor treatment.
Findings suggest that biomarkers reflecting reduced inflammation, absence of metastasis and potentially improved nutritional status may be associated with improved PFS and OS in patients with advanced NSCLC receiving ICIs.
Ilse Visser, E. Suazo-Zepeda, T. J. N. Hiltermann et al.
· Cancer Treatment and Researc... · 0 citations